I disagree on fundamentals. As per previous posts earlier should hold revenue guidance based on growth of Chinese label IF and retain similar levels of Daigou sales to H1. Would expect some margin contraction given need to accelerate Daigou. I’d say lower to mid $7 before a hopeful recovery - Daigou dependent - in FY 22
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-18348
-
-
- There are more pages in this discussion • 6,883 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B |
Open | High | Low | Value | Volume |
$6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12501 | $6.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.88 | 33092 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 292 | 6.840 |
2 | 8043 | 6.820 |
1 | 500 | 6.810 |
1 | 1100 | 6.800 |
2 | 9844 | 6.750 |
Price($) | Vol. | No. |
---|---|---|
6.880 | 23244 | 1 |
6.900 | 7848 | 10 |
6.910 | 1515 | 1 |
6.920 | 20500 | 2 |
6.950 | 17350 | 9 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |